#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial episode artwork

EPISODE · Oct 30, 2025 · 38 MIN

#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

from The Itch: Allergies, Asthma, Eczema & Immunology · host The Itch: Allergies, Asthma & Immunology

Mucus plugging is a challenge in asthma care. It’s thick, sticky mucus that blocks the airways and doesn’t respond to regular inhalers. Even when inflammation improves, these plugs can lower lung function, limit how well medicine works, and make asthma harder to control. In this episode, we break down the study: “Effect of Dupilumab on Mucus Burden in Patients with Moderate-to-Severe Asthma,” published October 28, 2025. The analysis looks at whether dupilumab (Dupixent), a biologic that blocks IL-4 and IL-13, can lower mucus burden and improve lung function, especially in people who start with a high “mucus plug score.” What we cover in our episode about dupilumab and mucus plugging Why mucus plugging matters in asthma: Discover how thick, sticky mucus can block airways, make it harder to breathe, and why standard inhalers and steroids don’t clear these plugs. How dupilumab may help: Learn how this biologic blocks IL-4 and IL-13, two key drivers of type 2 inflammation that increase mucus production and thickness. Inside the VESTIGE study: Hear how researchers measured mucus burden using CT scans and “mucus plug scores” to see if dupilumab could reduce plugging in moderate-to-severe asthma. What the results showed: Find out how dupilumab lowered mucus plug scores, reduced airway inflammation, and improved lung function (FEV₁), especially in people with high mucus burden. What this means for patients: Learn why identifying and treating mucus plugging may help improve breathing, reduce flare-ups, and make asthma easier to manage day to day. 📌INFOGRAPHIC to follow along  RESOURCES: What is asthma? What is type 2 inflammation? When Asthma Is More Than Just Asthma: Type 2 Inflammation More about dupilumab (Dupixent) The Itch Review, hosted by Dr. Gupta, Kortney, and Dr. Blaiss, explores allergy and immunology studies, breaking down complex research in conversations accessible to clinicians, patients, and caregivers. Each episode provides key insights from journal articles and includes a one-page infographic in the show notes for easy reference. ___ A special collaboration with the American Thoracic Society.  This podcast was made in partnership with Allergy & Asthma Network. This podcast is for informational purposes only and does not substitute professional medical advice. Always consult with your healthcare provider for any medical concerns.    

Episode metadata supplied by the publisher feed · Published Oct 30, 2025

Embed this episode

NOW PLAYING

#134 - How Dupilumab Reduces Mucus Burden in Asthma - VESTIGE Trial

0:00 38:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Itch: Allergies, Asthma, Eczema & Immunology?

This episode is 38 minutes long.

When was this The Itch: Allergies, Asthma, Eczema & Immunology episode published?

This episode was published on October 30, 2025.

Can I download this The Itch: Allergies, Asthma, Eczema & Immunology episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!